-
公开(公告)号:HRP20020172A2
公开(公告)日:2003-10-31
申请号:HRP20020172
申请日:2002-02-26
Applicant: HOFFMANN LA ROCHE
Inventor: TROTMANN GERDA HUBER , HUNKELER WALTER , JAKOB-ROETNE ROLAND , KILPATRICK GAVIN JOHN , NETTEKOVEN MATTHIAS HEINRICH , RIEMER CLAUS
IPC: C07D213/73 , A61K31/437 , A61K31/4418 , A61K31/444 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/635 , A61P9/10 , A61P11/06 , A61P11/16 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D409/04 , C07D471/04 , C07D519/00
Abstract: The invention relates to compounds of formulawhereinR1 is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, -(CH2)nOH, halogen or lower alkoxy, and wherein the heteroaryl groups may be optionally linked to the pyrazole ring via an alkylene or alkenyl group, or isphenyl, optionally substituted by one or two substituents being lower alkyl, hydroxy-lower alkyl, halogen, hydroxy or lower alkoxy or is-O(CH2)n,phenyl, benzofuryl, indolyl or benzothiophenyl, or is-S-lower alkyl;R2 and R4 are independently from each other hydrogen, cyano or -S(O)2-phenyl;R3 is hydrogen, halogen or isa 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, -(CH2)n-aryl, hydroxy, halogen, lower alkoxy, morpholinyl, amino, lower alkylamino or -C(O)NR'2, and wherein R' is lower alkyl or hydrogen, or isphenyl, optionally substituted by one or two substituents being halogen, lower alkyl, lower alkoxy, amino, di-lower alkyl amino, CF3, -OCF3, -NHC(O)lower alkyl, cyano, -C(O)-lower alkyl, -C(O)O-lower alkyl, -S-lower alkyl, -S(O)2NH-phenyl, -S(O)2-methylpiperazinyl; or is-NR'R'', wherein R' and R'' are independently from each other hydrogen, -(CH2)nphenyl, which phenyl ring is optionally substituted by halogen or lower alkoxy, -CH(lower alkyl)-phenyl, indan-1-yl, 1,2,3,4-tetrahydro-naphthalen, or cycloalkyl; or is-O-phenyl, which phenyl ring is optionally substituted by halogen, lower alkyl or lower alkoxy, -O-tetrahydronaphthalenyl or -O-CH2-6-methyl-pyridin-2-yl; or is-benzo[1,3]dioxolyl, -1H-indol-5-yl, naphthyl, benzofuran-2-yl, 1,3,4,9-tetrahydro-b-carbolin-2-yl, piperidin-1-yl, pyrrolidin-1-yl, piperazin-4-yl-methyl or morpholinyl;R5 is -NR2, wherein R may be the same or different and is hydrogen, lower alkyl, phenyl, benzyl, -CO-lower alkyl, -CO-lower alkoxy, -lower alkenyl, -CO(CH2)n-phenyl or -COO(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by CF3, lower alkoxy, halogen or lower alkyl, -CO(CH2)3-NHCO-lower alkoxy, -(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by lower alkoxy, CF3 or halogen, or is 4,5-dihydro-1H-imidazol-2-yl-benzoic acid, 1,4,5,6-tetrahydro-pyrimidin-2-yl-benzoic acid or 4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-yl-benzoic acid;n is 0-4and their pharmaceutically acceptable salts
-
32.
公开(公告)号:AR029614A1
公开(公告)日:2003-07-10
申请号:ARP000100737
申请日:2000-02-22
Applicant: HOFFMANN LA ROCHE
Inventor: BOES MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: A61K20060101 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/444 , A61K31/455 , A61K31/496 , A61P1/00 , A61P9/00 , A61P11/00 , A61P25/00 , A61P25/04 , A61P25/28 , A61P25/30 , A61P27/02 , A61P29/00 , A61P43/00 , C07D20060101 , C07D213/30 , C07D213/38 , C07D213/40 , C07D213/63 , C07D213/65 , C07D213/74 , C07D213/75 , C07D213/78 , C07D213/82 , C07D401/04 , C07D401/12 , C07D413/12 , C07D413/14 , C07D213/36 , C07D213/22 , C07D401/02 , A61K31/4406 , A61P1/43
Abstract: Derivados de 4-fenil-piridina de formula general (1), en donde R es hidrogeno, alquilo inferior, alcoxi inferior, halogeno o trifluorometilo; R1 es hidrogeno o halogeno; o R y R1 pueden ser conjuntamente -CH=CH-CH=CH-; R2 Y R2' son independientemente, hidrogeno, halogeno, triflurometilo, ciano o alcoxi inferior; o R2 y R2' pueden ser conjuntamente -CH=CH-CH=CH-, sustituido opcionalmente por uno o dos sustituyentes seleccionados del alquilo inferior o del alcoxi inferior; R3 es hidrogeno, alquilo inferior o forma un grupo cicloalquilo; R4 es hidrogeno, -N(R5)2, -N(R5) (CH2)nOH, -N(R5)S(O)2- alquilo inferior, -N(R5)S(O)2-fenilo, -N=CH-N(R5)2, -N(R5)C(O)R5 o una amina terciaria cíclica del grupo (2); R5 es independientemente, hidrogeno, C3-6-cicloalquilo, bencilo o alquilo inferior; R6 es hidrogeno, hidroxi, alquilo inferior, -(CH2)nCOO-alquilo inferior, -N(R5)CO-alquilo inferior, hidroxi-alquilo-inferior, ciano, -(CH2)nO(CH2)nOH, -CHO o un grupo heterocíclico de 5 o 6 miembros, unido opcionalmente por un grupo alquileno, X es -C(O)N(R5)-, -(CH2)mO-, -(CH2)mN(R5)-, -N(R5)C(O)-, o -N(R5) (CH2)m-; n es 0-4; y m es 1o 2; y sales derivadas de una adicion ácida farmacéuticamente aceptables. Los compuestos de formula (1) muestran una mayor afinidad por el receptor de NK-1. Estos se pueden usar para el tratamiento de enfermedades que estén relacionadas con antagonistas del receptor de NK-1.
-
公开(公告)号:DK1178990T3
公开(公告)日:2003-05-26
申请号:DK00936713
申请日:2000-05-05
Applicant: HOFFMANN LA ROCHE
Inventor: JENCK FRANCOIS , HUNKELER WALTER , MARTIN JAMES RICHARD , SLEIGHT ANDREW , HOFFMANN-EMERY FABIENNE
IPC: A61K31/5513 , A61K31/5517 , A61P25/08 , A61P25/20 , A61P25/22 , C07D487/04
Abstract: The present invention relates to compound 7-Chloro-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)-5-methyl-4,5-dihydro-imidazo[1,5-a][1,4]benzodiazepin-6-one (I)and to the use of the compound of formula I for the manufacture of medicaments to be used as anxiolytic and/or anticonvulsant and/or non-sedative sleep-inducing medicaments.
-
公开(公告)号:HU0201710A2
公开(公告)日:2002-10-28
申请号:HU0201710
申请日:2000-02-28
Applicant: HOFFMANN LA ROCHE
Inventor: BOES MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: C07D295/14 , A61K31/166 , A61K31/167 , A61K31/495 , A61K31/496 , A61P1/04 , A61P1/08 , A61P11/06 , A61P25/24 , A61P25/28 , A61P29/00 , A61P37/08 , A61P43/00 , C07C41/01 , C07C43/174 , C07C209/06 , C07C209/50 , C07C211/29 , C07C211/45 , C07C217/54 , C07C231/02 , C07C231/08 , C07C233/11 , C07C233/15 , C07C233/44 , C07C233/66 , C07C235/42 , C07D295/155
Abstract: The invention relates to compounds of the formulawhereinR is hydrogen, lower alkyl, lower alkoxy halogen, amino, -N(R6)2 or trifluoromethyl;R1 is hydrogen lower alkoxy or halogen,R and R1 may be together -CH=CH-CH=CH-;R2 is halogen, lower alkyl or trifluoromethyl;R3 is hydrogen or lower alkyl;R4 is hydrogen or a cyclic tertiary amine, optionally substituted by lower alkyl;R5 is hydrogen, nitro, amino or -N(R6)2;R6 is hydrogen or lower alkyl,X is -C(O)N(R6)-, -(CH2)nO-, (CH2)nN(R6)-, -N(R6)C(O)- or -N(R6)(CH2)n-; andn is 1 or 2;and pharmaceutically acceptable acid addition salts thereof.The compounds of formula I may be used for the treatment of diseases related to the NK-1 receptor.
-
公开(公告)号:HU0201527A2
公开(公告)日:2002-08-28
申请号:HU0201527
申请日:2000-05-24
Applicant: HOFFMANN LA ROCHE
Inventor: BOES MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: A61K31/505 , A61K31/506 , A61K31/513 , A61K31/5377 , A61P1/04 , A61P1/08 , A61P9/00 , A61P11/02 , A61P11/06 , A61P17/02 , A61P25/00 , A61P25/06 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P29/00 , A61P37/08 , A61P43/00 , C07D213/00 , C07D239/00 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/42 , C07D239/46 , C07D239/48 , C07D295/00 , C07D401/04
Abstract: Compounds of the general formula are described:whereinR is hydrogen or halogen;R is hydrogen, halogen, lower alkyl or lower alkoxy;R is halogen, trifluoromethyl, lower alkoxy or lower alkyl;R /R are each independently hydrogen or lower alkyl;R is lower alkyl, lower alkoxy, amino, hydroxy, hydroxy-lower alkyl, -(CH2)n-piperazinyl, optionally substituted by lower alkyl, -(CH2)n-morpholinyl, -(CH2)n+1-imidazolyl, -O-(CH2)n+1-morpholinyl, -O-(CH2)n+1-piperidinyl, lower alkyl-sulfanyl, lower alkyl-sulfonyl, benzylamino, -NH-(CH2)n+1N(R )2, -(CH2)n-NH-(CH2)n+1N(R )2, -(CH2)n+1N(R )2, or -O-(CH2)n+1N(R )2, wherein R is hydrogen or lower alkyl;R is hydrogen;R and R or R and R may together be -CH=CH-CH=CH-, wherein R and R or R and R , respectively, together with the two carbon ring atoms to which they are attached form a fused ring, with the proviso that n for R is 1;n is independently 0-2; andX is -C(O)N(R )- or -N(R )C(O)-;and pharmaceutically acceptable acid addition salts thereof.
-
公开(公告)号:HU0200124A2
公开(公告)日:2002-08-28
申请号:HU0200124
申请日:2000-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BOES MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: C07C211/44 , A61K31/167 , A61K31/44 , A61P25/00 , A61P29/00 , C07C211/54 , C07C233/29 , C07C233/33 , C07C233/44 , C07C317/14 , C07C317/40 , C07C323/41 , C07D213/75 , C07D213/79 , C07D213/81 , C07D295/12 , C07D295/135 , C07D401/04
Abstract: The present invention is a series of compounds formed from phenyl substituted pyridine or benzene derivatives and their pharmaceutically acceptable salts. These compounds have shown high affinity as antagonists to the NK-1 receptor.
-
公开(公告)号:ES2171109A1
公开(公告)日:2002-08-16
申请号:ES200000418
申请日:2000-02-23
Applicant: HOFFMANN LA ROCHE
Inventor: BOS MICHAEL , BRANCA QUIRICO , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER
IPC: A61K20060101 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/444 , A61K31/455 , A61K31/496 , A61P1/00 , A61P9/00 , A61P11/00 , A61P25/00 , A61P25/04 , A61P25/28 , A61P25/30 , A61P27/02 , A61P29/00 , A61P43/00 , C07D20060101 , C07D213/30 , C07D213/38 , C07D213/40 , C07D213/63 , C07D213/65 , C07D213/74 , C07D213/75 , C07D213/78 , C07D213/82 , C07D401/04 , C07D401/12 , C07D413/12 , C07D413/14 , C07D413/04
Abstract: Derivados de 4-fenil-piridina. Estos compuestos corresponden a la fórmula general (I) en donde los radicales R, R{sup,1}, R{sup,2}, R{sup,2''}, R{sup,3}, R{sup,4}, X, n y m son como se expresan en las reivindicaciones. Estos compuestos muestran una mayor afinidad por el receptor de NK-1. La invención también se refiere a sales derivadas de los compuestos que sean farmaceúticamente aceptables, a medicamentos que contengan uno o más de estos compuestos, y a un proceso para la preparación de los compuestos. Los productos de la invención se pueden usar para el tratamiento de enfermedades relacionadas con antagonistas del receptor de NK-1.
-
公开(公告)号:HU0200139A2
公开(公告)日:2002-06-29
申请号:HU0200139
申请日:2000-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BOES MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: A61K31/44 , A61P25/00 , A61P29/00 , C07D213/30 , C07D213/38 , C07D213/75 , C07D213/81 , C07D401/04
Abstract: The invention relates to compounds of the formulawhereinR is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl;R1 is hydrogen or halogen; orR and R1 may be together -CH=CH-CH=CH-;R2 is hydrogen, halogen, trifluoromethyl, lower alkoxy or cyano;R3 is hydrogen, lower alkyl or form a cycloalkyl group;R4 is hydrogen, -N(R5)2, -N(R5)S(O)2-lower alkyl, -N(R5)C(O)R5 or a cyclic tertiary amine of the groupR5 is, independently from each other, hydrogen, C3-6-cycloalkyl, benzyl or lower alkyl;R6 is hydrogen, hydroxy, lower alkyl, -N(R5)CO-lower alkyl, hydroxy-lower alkyl, cyano, -CHO or a 5- or 6 membered heterocyclic group, optionally bonded via an alkylene group,X is -C(O)N(R5)-, -(CH2)mO-, -(CH2)mN(R5)-, -N(R5)C(O)-, or -N(R5)(CH2)m-;n is 0-4; andm is 1 or 2;and to pharmaceutically acceptable acid addition salts thereof.It has been shown that the above mentioned compounds have a good affinity to the NK-1 receptor.
-
公开(公告)号:CO5160261A1
公开(公告)日:2002-05-30
申请号:CO00016011
申请日:2000-03-06
Applicant: HOFFMANN LA ROCHE
Inventor: BOS MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: C07D295/14 , A61K31/165 , A61K31/166 , A61K31/167 , A61K31/495 , A61K31/496 , A61P1/04 , A61P1/08 , A61P11/06 , A61P25/24 , A61P25/28 , A61P29/00 , A61P37/08 , A61P43/00 , C07C41/01 , C07C43/174 , C07C209/06 , C07C209/50 , C07C211/29 , C07C211/45 , C07C217/54 , C07C231/02 , C07C231/08 , C07C233/11 , C07C233/15 , C07C233/44 , C07C233/66 , C07C235/42 , C07D295/155
Abstract: Compuestos de la fórmula general en dondeR es hidrógeno, alquilo inferior, alcoxi inferior, halógeno, amino, -N(R6)2 ó trifluorometilo; R1 es hidrógeno, alcoxi inferior o halógeno;R y R1 pueden ser conjuntamente -CH=CH-CH=CH-;R2 es halógeno, alquilo inferior o trifluorometilo;R3 es hidrógeno o alquilo inferior;R4 es hidrógeno o una amina terciaria cíclica, sustituida opcionalmente por alquilo inferior;R5 es hidrógeno, nitro, amino ó -N(R6)2;R6 es hidrógeno o alquilo inferior;X es -C(O)N(R6)-, -(CH2)nO-, -(CH2)nN(R6)-, -N(R6)C(O)- ó -N(R6) (CH2)n-; yn es 1-2;y sales derivadas de una adición ácida farmacéuticamenteaceptables.
-
公开(公告)号:CO5140088A1
公开(公告)日:2002-03-22
申请号:CO00012296
申请日:2000-02-22
Applicant: HOFFMANN LA ROCHE
Inventor: BOS MICHAEL , GALLEY GUIDO , GODEL THIERRY , HOFFMANN TORSTEN , HUNKELER WALTER , SCHNIDER PATRICK , STADLER HEINZ
IPC: C07C211/44 , A61K31/03 , A61K31/165 , A61K31/167 , A61K31/44 , A61K31/445 , A61P25/00 , A61P29/00 , C07C211/54 , C07C233/29 , C07C233/33 , C07C233/44 , C07C317/14 , C07C317/40 , C07C323/41 , C07D213/75 , C07D213/79 , C07D213/81 , C07D295/12 , C07D295/135 , C07D401/04
Abstract: Compuestos de la fórmula general en dondeR es hidrógeno, alquilo inferior, alcoxi inferior, halógeno o trifluorometilo;R1 es hidrógeno o halógeno; oR y R1 pueden ser conjuntamente -CH=CH-CH=CH-;R2 es hidrógeno, halógeno, trifluorometilo, alcoxi inferior o ciano;R3 es independientemente uno de otro, hidrógeno, alquilo inferior o forma un grupo cicloalquilo;R4 es hidrógeno, halógeno, alquilo inferior, alcoxi inferior, -N(R5)2, -N(R5)S(O)2- alquilo inferior, -N(R5)C(O)R5 o una amina terciaria cíclica del grupo R5 es independientemente uno de otro, hidrógeno, C3-6-cicloalquilo, bencilo o alquilo inferior;R6 es hidrógeno, hidroxi, alquilo inferior, -N(R5)CO-alquilo inferior, hidroxi-alquilo-inferior, ciano, -CHO o un grupo heterocíclico de 5 ó 6 miembros, unido opcionalmente por un grupo alquileno,X es -C(0)N(R5)-, -(CH2)mO-, -(CH2)mN(R5)-,-N(R5)C(0)-, -C(O)O-, ó -N(R5)(CH2)m-;Y es -(CH2)n, -O-, -S-, -S02-, -C(O)- ó -N(R5)-;Z es =N-, -CH= ó -C(CI)=;n es 0-4; ym es 1 ó 2;y sales derivadas de una adición ácida farmacéuticamente aceptables.
-
-
-
-
-
-
-
-
-